NASDAQ · ECOR
electroCore, Inc.
$8.11-$0.31 (-3.68%)
electroCore, Inc.’s quoted price sits in the lower half of its reported 52-week range, 36.14% below the high.
Loading market information…
AMEX · MYO · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Myomo, Inc.’s quoted price sits in the upper half of its reported 52-week range, 31.22% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Myomo, Inc.’s next earnings report is currently expected on Nov 9, 2026, with estimated earnings per share of -$0.08. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Myomo, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:57 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 |
|---|
| May 7, 2025 |
| -$0.080.0% vs estimate |
| $9.83M+6.62% vs estimate |
| Q4 2024 | Mar 10, 2025 | -$0.01+50.0% vs estimate | $12.07M+52.31% vs estimate |
|---|
| Q3 2024 | Nov 6, 2024 | -$0.03-28.59% vs estimate | $9.21M-6.97% vs estimate |
|---|
THE ANALYST VIEW
8 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$8.11-$0.31 (-3.68%)
electroCore, Inc.’s quoted price sits in the lower half of its reported 52-week range, 36.14% below the high.
$3.51+$0.51 (+16.83%)
Hyperion DeFi, Inc.’s quoted price sits in the lower half of its reported 52-week range, 52.95% below the high.
$4.59+$0.25 (+5.76%)
Precision Optics Corporation, Inc.’s quoted price sits in the lower half of its reported 52-week range, 25.37% below the high.
$0.32-$0.00 (-0.54%)
Milestone Scientific Inc.’s quoted price sits in the lower half of its reported 52-week range, 45.69% below the high.
$0.57+$0.02 (+2.79%)
MIRA Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 67.34% below the high.
$0.20-$0.04 (-16.55%)
IGC Pharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 55.81% below the high.
$1.72-$0.19 (-9.95%)
Modular Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.79% below the high.
$0.97+$0.11 (+12.96%)
NeuroOne Medical Technologies Corporation’s quoted price sits in the lower half of its reported 52-week range, 84.15% below the high.
